Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia

British Journal of Anaesthesia

Volumn 108, Issue 2, 2012, Pages 236-239

  Gaszynski, T ^a   Szewczyk, T ^a   Gaszynski, W ^a  

^a N Barlicki University Hospital No 1 of Medical University of Lodz   (Poland)

Author keywords

morbid obesity; neostigmine; neuromuscular block; sugammadex

Indexed keywords

NEOSTIGMINE; ROCURONIUM; SUGAMMADEX;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DOSE CALCULATION; DRUG EFFICACY; EXTUBATION; GENERAL ANESTHESIA; HUMAN; MAJOR CLINICAL STUDY; MORBID OBESITY; MUSCLE RELAXATION; NEUROMUSCULAR FUNCTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE RESIDUAL CURARIZATION; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM;

EID: 84856285500     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer330     Document Type: Article

References (17)

1. Gaszynski T, Szlachcinski Ł, Jakubiak J, Gaszynski W. Ocena prze-wodnictwa nerwowo-miesniowego po operacjach wykonywanych w znieczuleniu ogolnym z zastosowaniem niedepolaryzuja?cych srodkow zwiotczajacych. Anestezjol Intens Ter 2009; 41: 11-5
2. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107: 103-7
3. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: a prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pan-curonium. Acta Anaesthesiol Scand 1997; 41: 1095-103
4. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-84 (Pubitemid 30180973)
5. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84: 301-3 (Pubitemid 30114121)
6. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neu-romuscular block: a survey of management. Br J Anaesth 2005; 95: 622-6 (Pubitemid 41600023)
7. De Baerdemaeker LEC, Mortier EP, Struys M. Pharmacokinetics in obese patients. Contin Educ Anaesth Crit Care Pain 2004; 4: 152-5
8. Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacody-namic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007; 51: 789-808 (Pubitemid 47063004)
9. Gaszynski T, Jakubiak J, Szlachcinski L, Gaszynski W. Administration of neostigmine does not prevent from post-operative residual curarisation in morbidly obese patients. Eur J Anaesthe-siol 2008; 25(Suppl. 44): 137(9AP5-7)
10. Eikermann M, Groeben H, Husing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98: 1333-7 (Pubitemid 36622464)
11. Jones PM, Turkstra TP. Urgent usage of sugammadex to treat residual neuromuscular blockade in the PACU. Anesth Analg 2007; 105: 877 (Pubitemid 47300878)
12. Monk TG, Rietbergen H, Woo T. Obesity has no clinically relevant impact upon recovery time following administration of sugam-madex. Presented at Annual Meeting of American Society of Anesthesiologists, October 18-22, 2008, Orlando, FL. Abstract A682
13. Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br J Anaesth 2006; 97: 160-3 (Pubitemid 44295699)
14. Flockton EA, Mastronardi P, Hunter JM, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostig-mine. Br J Anaesth 2008; 100: 622-30 (Pubitemid 351774353)
15. Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Anesth Analg 2007; 104: 569-74
16. Yang LPH, Keam SJ. Sugammadex: a review of its use in anaesthetic practice. Adis drug evaluations. Drugs 2009; 69: 919-42
17. Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104: 667-74